Free Trial

Select Medical (SEM) Projected to Post Earnings on Thursday

Select Medical logo with Medical background

Select Medical (NYSE:SEM - Get Free Report) will likely be posting its Q2 2025 quarterly earnings results after the market closes on Thursday, July 31st. Analysts expect the company to announce earnings of $0.24 per share and revenue of $1.35 billion for the quarter.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.01). The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.40 billion. Select Medical had a return on equity of 11.04% and a net margin of 2.81%. The company's revenue for the quarter was down 24.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.75 EPS. On average, analysts expect Select Medical to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Select Medical Price Performance

NYSE SEM traded up $0.08 during trading on Friday, reaching $14.22. The company's stock had a trading volume of 765,686 shares, compared to its average volume of 999,446. The firm has a fifty day moving average of $14.92 and a 200 day moving average of $16.62. Select Medical has a one year low of $14.00 and a one year high of $40.98. The stock has a market capitalization of $1.83 billion, a PE ratio of 10.61, a P/E/G ratio of 0.76 and a beta of 1.32. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.16 and a quick ratio of 1.16.

Select Medical Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were given a $0.0625 dividend. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $0.25 annualized dividend and a yield of 1.76%. Select Medical's dividend payout ratio (DPR) is presently 18.66%.

Select Medical declared that its Board of Directors has authorized a share buyback plan on Thursday, May 1st that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the health services provider to repurchase up to 42.6% of its shares through open market purchases. Shares buyback plans are often an indication that the company's management believes its stock is undervalued.

Analyst Upgrades and Downgrades

SEM has been the subject of several analyst reports. Royal Bank Of Canada dropped their target price on Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a report on Wednesday, May 7th. Mizuho assumed coverage on shares of Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $26.00.

View Our Latest Report on Select Medical

Insider Activity at Select Medical

In other Select Medical news, CEO David S. Chernow sold 225,000 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the sale, the chief executive officer owned 714,516 shares in the company, valued at approximately $12,861,288. This trade represents a 23.95% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Parvinderjit S. Khanuja purchased 21,000 shares of the company's stock in a transaction on Monday, May 5th. The stock was purchased at an average price of $15.02 per share, with a total value of $315,420.00. Following the completion of the transaction, the director owned 65,089 shares of the company's stock, valued at approximately $977,636.78. This trade represents a 47.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 11.60% of the company's stock.

Institutional Investors Weigh In On Select Medical

Several institutional investors and hedge funds have recently modified their holdings of the stock. Goldman Sachs Group Inc. lifted its position in Select Medical by 25.3% during the first quarter. Goldman Sachs Group Inc. now owns 728,689 shares of the health services provider's stock valued at $12,169,000 after purchasing an additional 147,183 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Select Medical by 3.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 323,968 shares of the health services provider's stock valued at $5,410,000 after acquiring an additional 10,329 shares during the last quarter. Jane Street Group LLC purchased a new position in Select Medical in the first quarter worth about $4,635,000. Royal Bank of Canada increased its stake in Select Medical by 8.5% during the first quarter. Royal Bank of Canada now owns 95,771 shares of the health services provider's stock worth $1,599,000 after acquiring an additional 7,502 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Select Medical by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 64,400 shares of the health services provider's stock valued at $1,075,000 after purchasing an additional 2,809 shares during the last quarter. Institutional investors own 89.48% of the company's stock.

Select Medical Company Profile

(Get Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Stories

Earnings History for Select Medical (NYSE:SEM)

Should You Invest $1,000 in Select Medical Right Now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress is Dumping these 3 Stocks
3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines